Blood Cancer Journal (Oct 2022)
TET2 deficiency promotes MDS-associated leukemogenesis
- Feiteng Huang,
- Jie Sun,
- Wei Chen,
- Lei Zhang,
- Xin He,
- Haojie Dong,
- Yuhui Wu,
- Hanying Wang,
- Zheng Li,
- Brian Ball,
- Samer Khaled,
- Guido Marcucci,
- Ling Li
Affiliations
- Feiteng Huang
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- Jie Sun
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- Wei Chen
- The Integrative Genomics Core, Beckman Research Institute, City of Hope Medical Center
- Lei Zhang
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- Xin He
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- Haojie Dong
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- Yuhui Wu
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- Hanying Wang
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- Zheng Li
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- Brian Ball
- Department of Hematology and Hematopoietic Cell Transplantation (HCT), Beckman Research Institute, City of Hope Medical Center
- Samer Khaled
- Department of Hematology and Hematopoietic Cell Transplantation (HCT), Beckman Research Institute, City of Hope Medical Center
- Guido Marcucci
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- Ling Li
- Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center
- DOI
- https://doi.org/10.1038/s41408-022-00739-w
- Journal volume & issue
-
Vol. 12,
no. 10
pp. 1 – 5
Abstract
No abstracts available.
